Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-25

FDA Approved: OXYBUTYNIN CHLORIDE — Supplemental Application (Ajanta Pharma USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Oxybutynin Chloride submitted by Ajanta Pharma USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

SUPPL AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)